TECHNOLOGY · SOURCE PLATFORM 02

02.1B

ChitoGene.
Fermentation-level control.

ChitoGene uses recombinant yeast and proprietary fermentation to create high-purity, repeatable non-animal chitosan for demanding medical and pharmaceutical development pathways.

THE PLATFORM

02.1B.1

From master cell line
to engineered performance.

ChitoGene starts with a secure, consistent biological source and adds molecular, endotoxin and bioabsorbability control around the intended application.

ChitoGene performance platform showing fermentation, EndoFree and ABC performance steps
ChitoGene performance architecture supplied by Mykito Sciences.

CHITOGENE ADVANTAGES

01

Controlled fermentation

A proprietary yeast platform provides a controlled biological starting point for repeatable chitosan production.

02

Purity + traceability

Master-cell-line control and documented processing support high-purity material, reproducibility and complete batch traceability.

03

High-performance options

EndoFree and ABC pathways extend the platform toward low-endotoxin and absorbable, biocompatible material development.

COMPARE THE PLATFORMS

Need flexible, scalable fungal feedstocks?

Explore BioFoundry